ABG Acquisition Corp. I

General Information

We intend to focus on healthcare or healthcare-related industries, which can benefit from the expertise and capabilities of our management team in order to create long-term shareholder value. (Incorporated in the Cayman Islands.)

Our sponsor is an affiliate of Ally Bridge Group, a global healthcare-focused investment group founded by Fan (Frank) Yu with dual-headquarters in New York and Hong Kong. Mr. Yu and his team began their track record of successful healthcare investing in 2011 in China and have since become global healthcare investors with a strong U.S. focus. ABG currently manages or advises over $2.5 billion in healthcare assets, with a portfolio of what we believe to be some of the world’s most novel life science companies and technologies based in the United States, Europe and China. ABG primarily focuses on high-impact investments in cutting-edge life science innovations in the U.S. across the med tech, tools and diagnostics, biopharmaceutics and, increasingly, digital health and telemedicine sectors. ABG has successfully invested through the following strategies: i) venture; ii) private equity, including buyout and growth capital; and iii) public equity.

(Note: ABG Acquisition Corp. I upsized its IPO at pricing on Feb. 16, 2021, to 13.1 million Class A ordinary shares, up from 12 million shares, at $10 each to raise $131.0 million. This is a IPO of Class A ordinary shares, NOT the typical SPAC unit offering.)

Employees: 0
Founded: 2020
Contact Information
Address 430 Park Avenue, 12th Floor New York, NY 10022
Phone Number 1 (646) 829-9373
Web Address
View Prospectus: ABG Acquisition Corp. I
Financial Information
Market Cap
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol ABGI
Exchange NASDAQ
Shares (millions): 13.1
Price range $10.00 - $10.00
Est. $ Volume $131.0 mil
Manager / Joint Managers Jefferies
CO-Managers -
Expected To Trade: 2/17/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change